Cargando…
Color Vision in Blue Cone Monochromacy: Outcome Measures for a Clinical Trial
PURPOSE: Blue cone monochromacy (BCM) is an X-linked retinopathy due to mutations in the OPN1LW/OPN1MW gene cluster. Symptoms include reduced visual acuity and disturbed color vision. We studied BCM color vision to determine outcome measures for future clinical trials. METHODS: Patients with BCM and...
Autores principales: | Mascio, Abraham A., Roman, Alejandro J., Cideciyan, Artur V., Sheplock, Rebecca, Wu, Vivian, Garafalo, Alexandra V., Sumaroka, Alexander, Pirkle, Sydney, Kohl, Susanne, Wissinger, Bernd, Jacobson, Samuel G., Barbur, John L. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Association for Research in Vision and Ophthalmology
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9896867/ https://www.ncbi.nlm.nih.gov/pubmed/36692456 http://dx.doi.org/10.1167/tvst.12.1.25 |
Ejemplares similares
-
Foveal Therapy in Blue Cone Monochromacy: Predictions of Visual Potential From Artificial Intelligence
por: Sumaroka, Alexander, et al.
Publicado: (2020) -
Treatment Potential for Macular Cone Vision in Leber Congenital Amaurosis Due to CEP290 or NPHP5 Mutations: Predictions From Artificial Intelligence
por: Sumaroka, Alexander, et al.
Publicado: (2019) -
Foveal Cone Structure in Patients With Blue Cone Monochromacy
por: Patterson, Emily J., et al.
Publicado: (2022) -
Blue Cone Monochromacy: Visual Function and Efficacy Outcome Measures for Clinical Trials
por: Luo, Xunda, et al.
Publicado: (2015) -
Reading Performance in Blue Cone Monochromacy: Defining an Outcome Measure for a Clinical Trial
por: Semenov, Evelyn P., et al.
Publicado: (2020)